Mereo BioPharma Group plc (MREO)

NASDAQ: MREO · IEX Real-Time Price · USD

2.640

-0.010 (-0.38%)

At close: Apr 19, 2024, 4:00 PM

2.650

+0.010 (0.38%)

After-hours: Apr 19, 2024, 6:20 PM EDT

Mereo BioPharma Group Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	57.42	68.18	117.87	29.34	20.43	31.3	62.56	66.97
Short-Term Investments	0	0	0	0	0	3.13	3.13	0
Cash & Cash Equivalents	57.42	68.18	117.87	29.34	20.43	34.43	65.68	66.97
Cash Growth	-15.78%	-42.15%	301.79%	43.57%	-40.65%	-47.58%	-1.93%	-
Receivables	0	0	1.77	1.27	0.72	0.76	0.64	0.96
Other Current Assets	6.34	7.02	4.51	6.55	16.9	7.93	12.65	8.04
Total Current Assets	63.76	75.2	124.15	37.16	38.04	43.12	78.97	75.97
Property, Plant & Equipment	1.65	2.22	3.16	1.97	14.45	0.19	0.19	0.22
Goodwill and Intangibles	1.09	0	30.71	39.56	55.57	40.79	41.26	32.27
Other Long-Term Assets	0	0	0	0	0	0	0	0
Total Long-Term Assets	2.74	2.22	33.87	41.53	70.02	40.98	41.45	32.48
Total Assets	66.5	77.41	158.02	78.68	108.06	84.1	120.42	108.46
Accounts Payable	2.35	3.49	3.12	4.17	7.94	5.71	3.78	1.4
Current Debt	0.65	13.89	0.78	0.8	22.16	8.55	2.42	0
Other Current Liabilities	6.49	6.99	11.78	5.75	7.25	5.96	5.82	2.61
Total Current Liabilities	9.49	24.38	15.68	10.71	37.35	20.22	12.02	4.01
Long-Term Debt	5.3	1.48	20.17	21.63	18.36	18.31	23.52	3.91
Other Long-Term Liabilities	1.18	0.16	12.17	65.07	2.03	4.6	6.78	1.47
Total Long-Term Liabilities	6.48	1.64	32.34	86.69	20.39	22.91	30.29	5.37
Total Liabilities	15.96	26.01	48.02	97.4	57.74	43.13	42.31	9.39
Total Debt	5.95	15.37	20.95	22.42	40.52	26.86	25.94	3.91
Debt Growth	-61.27%	-26.64%	-6.56%	-44.67%	50.88%	3.53%	563.75%	-
Retained Earnings	-419.63	-404.58	-371.21	-387.12	-182.58	-139.03	-99.14	-50.72
Comprehensive Income	-17.49	-21.69	-0.43	-0.19	-0.62	0	0	0
Shareholders' Equity	50.54	51.4	110	-18.71	50.32	40.96	78.1	99.07
Net Cash / Debt	51.47	52.81	96.92	6.92	-20.09	7.57	39.74	63.06
Net Cash / Debt Growth	-2.54%	-45.51%	1301.34%	-	-	-80.95%	-36.98%	-
Net Cash Per Share	0.08	0.09	-	-	-	-	-	-
Working Capital	54.27	50.82	108.48	26.45	0.7	22.9	66.95	71.96
Book Value Per Share	0.38	0.43	1.01	-0.28	3.54	2.35	4.49	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).